CLSI document MM28 will provide information on clinical utility, technologies, validation, and results interpretation and reporting of oncology liquid biopsy testing. The methods and recommendations discussed in MM28 will focus primarily on detection of somatic genetic abnormalities, which are distinct ...
10-01-2023 | Reviewer or Advisor